Skip to content

PENG & QoR-15: a systematic review and meta-analysis

Effect of pericapsular nerve group (PENG) block on quality of postoperative recovery for patients undergoing hip arthroplasty: a systematic review and meta-analysis

Status
Active, not recruiting
Phases
Unknown
Study type
Unknown
Source
JPRN
Registry ID
JPRN-jRCT1030240521
Enrollment
1000
Registered
2024-12-05
Start date
2024-12-05
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

patients who receive hip arthoplasty, including total hip arthroplasty, hemiarthroplasty

Interventions

PENG block

Sponsors

Jin Zhuan
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Eligible studies included prospectively registered clinical trials in forms of articles on peer-reviewed journals, letters, or conference abstracts, where (1) adult patients who received any types of hip arthroplasty under either general or spinal anesthesia; (2) patients were allocated to PENG block (including ultrasound-guided, X-ray-guided, CT-guided or traditional landmark-based techniques) as an intervention compared with any other kind of analgesia management other than PENG block for perioperative pain management. No language restrictions were applied. Studies published as Non-English, Chinese, Japanese studies were translated using an online translator.

Exclusion criteria

Exclusion criteria: Exclusion criteria include: (1) studies that had another block as a co-intervention, except for lateral femoral cutaneous nerve (LFCN) block or infiltration using local anesthetics; (2) studies of catheter-based continuous blocks; (3) studies where both intervention and comparison were PENG block; (4) studies with data that could not be used for statistical analysis, or studies with incomplete data, or data that could not be extracted after contacting the original authors; and (5) studies that were duplicate publications, or not prospectively registered.

Design outcomes

Primary

MeasureTime frame
QoR-15, QoR-40 score on POD1 (evaluated within 24 hours from surgery, on postoperative day 1, or on the second day of surgery)

Secondary

MeasureTime frame
(1) QoR-15 score reported in other time frame: 48 hours or on POD2, etc. (2) QoR-40 score reported in any time frame: POD1, POD2, etc. (3) Time to first mobilization: the time from the end of surgery to the first mobilization, ambulation, walk, or getting up from bed (4) First ambulation distance (5) First up-and-go test (6) Quadriceps strength on POD1 (7) Other evaluation tool of recovery or patient-reported outcomes, such as the Hip disability and Osteoarthritis Outcome Score for Joint Replacement (HOOS, JR.), the Patient-Reported Outcomes Measurement Information System (PROMIS) (8) Patient satisfaction: any satisfaction questionnaire results with perioperative pain management techniques or postoperative analgesia evaluated on a certain scale were included (9) Postoperative complications reported if possible

Contacts

Public ContactZhuan Jin

Kameda Medical Center

jin.zhuan@kameda.jp+81-4-7092-2211

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026